JP2004501939A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004501939A5 JP2004501939A5 JP2002506679A JP2002506679A JP2004501939A5 JP 2004501939 A5 JP2004501939 A5 JP 2004501939A5 JP 2002506679 A JP2002506679 A JP 2002506679A JP 2002506679 A JP2002506679 A JP 2002506679A JP 2004501939 A5 JP2004501939 A5 JP 2004501939A5
- Authority
- JP
- Japan
- Prior art keywords
- ivermectin
- present
- use according
- pharmaceutically acceptable
- acceptable carrier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- AZSNMRSAGSSBNP-XPNPUAGNSA-N 22,23-dihydroavermectin B1a Chemical compound C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 AZSNMRSAGSSBNP-XPNPUAGNSA-N 0.000 description 4
- 229960002418 Ivermectin Drugs 0.000 description 4
- 239000003937 drug carrier Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 208000008742 Seborrheic Dermatitis Diseases 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 230000000699 topical Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/605,747 US6319945B1 (en) | 2000-06-29 | 2000-06-29 | Method of treatment of seborrheic dermatitis |
| PCT/US2001/041159 WO2002002056A2 (en) | 2000-06-29 | 2001-06-27 | Method of treatment of seborrheic dermatitis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004501939A JP2004501939A (ja) | 2004-01-22 |
| JP2004501939A5 true JP2004501939A5 (US20050276830A1-20051215-C00012.png) | 2006-03-30 |
| JP3802485B2 JP3802485B2 (ja) | 2006-07-26 |
Family
ID=24425042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002506679A Expired - Fee Related JP3802485B2 (ja) | 2000-06-29 | 2001-06-27 | 脂漏性皮膚炎の処置方法 |
Country Status (10)
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6399651B1 (en) * | 2000-06-29 | 2002-06-04 | L. Dean Parks | Method of treating dermatoses using avermectin compound |
| US7897559B2 (en) * | 2000-06-29 | 2011-03-01 | Parks L Dean | Dermatological composition and kit containing avermectin compound for treating dermatological conditions |
| EP1376516B1 (en) | 2002-06-26 | 2008-05-21 | Avery Dennison Corporation | Machine direction oriented polymeric films |
| BRPI0410503B8 (pt) | 2003-04-24 | 2021-05-25 | Galderma Sa | composição tópica e uso da composição |
| FR2854074B1 (fr) * | 2003-04-24 | 2007-11-23 | Galderma Res & Dev | Utilisation de l'ivermectine pour le traitement de desordres dermatologiques |
| FR2867684B1 (fr) * | 2004-03-18 | 2006-05-05 | Galderma Sa | Gel creme contenant de l'ivermectine |
| FR2894823B1 (fr) * | 2005-12-20 | 2008-02-29 | Galderma Sa | Composition de type emulsion inverse comprenant de l'ivermectine, et ses utilisations en cosmetique et en dermatologie |
| ES2398725T3 (es) | 2006-06-14 | 2013-03-21 | Avery Dennison Corporation | Material para etiquetas orientado en la dirección longitudinal que se puede conformar y cortar con troquel y etiquetas y proceso para su preparación |
| US9636895B2 (en) | 2006-06-20 | 2017-05-02 | Avery Dennison Corporation | Multilayered polymeric film for hot melt adhesive labeling and label stock and label thereof |
| EP2091325B1 (en) | 2006-10-12 | 2014-08-06 | Topaz Pharmaceuticals Inc. | Shampoo-conditioner formulations comprising an avermectin for elimination of, and prophylaxis against, susceptible and treatment-resistant strains of lice |
| US8901163B2 (en) | 2007-01-03 | 2014-12-02 | Galderma S.A. | Method of treating hyperesthesia, paresthesia, dolor, and pruritus caused by insect stings or noxious weeds or plants using avermectin compound |
| WO2012054328A1 (en) | 2010-10-20 | 2012-04-26 | Galderma S.A. | Method of treating hemorrhoids using macrocyclic lactone compound |
| WO2012054331A1 (en) | 2010-10-20 | 2012-04-26 | Galderma S.A. | Method of treating otitis externa using macrocyclic lactone compound |
| US9233117B2 (en) | 2013-07-08 | 2016-01-12 | Galderma S. A. | Treatment of inflammatory lesions of rosacea with ivermectin |
| US9782425B2 (en) | 2013-07-08 | 2017-10-10 | Galderma S.A. | Treatment of papulopustular rosacea with ivermectin |
| EP3149097A1 (en) | 2014-06-02 | 2017-04-05 | Avery Dennison Corporation | Films with enhanced scuff resistance, clarity, and conformability |
| CN110604741A (zh) * | 2018-06-15 | 2019-12-24 | 瑞恩生化科技有限公司 | 抑制皮肤细胞增生的组合物及其应用 |
| EP4062907A1 (fr) | 2021-03-23 | 2022-09-28 | Substipharm | Formulation par voie orale d'ivermectine et utilisations |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5439924A (en) * | 1991-12-23 | 1995-08-08 | Virbac, Inc. | Systemic control of parasites |
| US5877295A (en) * | 1992-09-30 | 1999-03-02 | The Center For Blood Research | Antibodies which bind a subpopulation of Mac-1 (CD11b/CD18) molecules which mediate neutrophil adhesion to ICAM-1 and fibrinogen |
| DE4328689A1 (de) * | 1993-08-26 | 1995-03-02 | Beiersdorf Ag | Verfahren zur Detektion und Zählung von Mikroorganismen |
| US5786344A (en) * | 1994-07-05 | 1998-07-28 | Arch Development Corporation | Camptothecin drug combinations and methods with reduced side effects |
| US5654312A (en) * | 1995-06-07 | 1997-08-05 | Andrulis Pharmaceuticals | Treatment of inflammatory and/or autoimmune dermatoses with thalidomide alone or in combination with other agents |
| ES2319699T3 (es) * | 1996-05-20 | 2009-05-11 | Otsuka Pharmaceutical Co., Ltd. | Remedio para la rosacea. |
| US5952372A (en) * | 1998-09-17 | 1999-09-14 | Mcdaniel; William Robert | Method for treating rosacea using oral or topical ivermectin |
| KR100315465B1 (ko) * | 1998-11-23 | 2002-02-19 | 성재갑 | 수용성고분자와알코올을포함하는주사제용동물구충제조성물 |
-
2000
- 2000-06-29 US US09/605,747 patent/US6319945B1/en not_active Expired - Lifetime
-
2001
- 2001-06-27 AU AU2002216748A patent/AU2002216748A1/en not_active Abandoned
- 2001-06-27 JP JP2002506679A patent/JP3802485B2/ja not_active Expired - Fee Related
- 2001-06-27 AT AT01984091T patent/ATE314068T1/de not_active IP Right Cessation
- 2001-06-27 CA CA002384448A patent/CA2384448C/en not_active Expired - Fee Related
- 2001-06-27 WO PCT/US2001/041159 patent/WO2002002056A2/en active IP Right Grant
- 2001-06-27 EP EP01984091A patent/EP1294375B1/en not_active Expired - Lifetime
- 2001-06-27 ES ES01984091T patent/ES2252312T3/es not_active Expired - Lifetime
- 2001-06-27 DE DE60116302T patent/DE60116302T2/de not_active Expired - Lifetime
- 2001-06-27 CN CNB018018572A patent/CN1171588C/zh not_active Expired - Fee Related
- 2001-10-12 US US09/976,914 patent/US6433006B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004501939A5 (US20050276830A1-20051215-C00012.png) | ||
| WO2002042462A3 (en) | Therapeutic agents and methods of use thereof for treating an amyloidogenic disease | |
| AR025071A1 (es) | Aditivo para mejorar la resistencia al agua de formulaciones cosmeticas o dermatologicas | |
| WO2001043775A3 (en) | Hydroxide-releasing agents as skin permeation enhancers | |
| BR0204596A (pt) | Composição tópica, e, métodos para melhorar a aparência estética da pele, para intensificar a eficácia terapêutica de uma composição tópica para a pele, unha, lábios e/ou cabelo e para intensificar a produção de um constituinte de célula de planta predeterminada | |
| IL154693A (en) | Use of testosterone gel to make a remedy for testosterone deficiency in women | |
| JP2004500353A5 (US20050276830A1-20051215-C00012.png) | ||
| AR015744A1 (es) | Uso de dexmedetomidina para sedacion en terapia intensiva | |
| CA2384448A1 (en) | Method of treatment of seborrheic dermatitis | |
| MXPA01009951A (es) | Composicion para aumentar permeacion de agentes topicos de la piel. | |
| US6855342B2 (en) | Compositions and methods for high sorption of skin materials and delivery of sulfur | |
| JP2002537232A5 (US20050276830A1-20051215-C00012.png) | ||
| JP2003503453A5 (ja) | ガバペンチンおよびプレガバリンを含む相乗作用組成物 | |
| NZ516765A (en) | Topical formulations comprising skin penetration agents and the use thereof | |
| JP2003523397A5 (US20050276830A1-20051215-C00012.png) | ||
| CO5180574A1 (es) | Micofenolato mofetil en asociacion con peg-inf-a | |
| ES2189886T3 (es) | Composicion farmaceutica para aplicacion topica. | |
| CA2474703A1 (en) | Therapeutic agent of glaucoma comprising bunazosin and prostaglandins | |
| JP2002501021A5 (US20050276830A1-20051215-C00012.png) | ||
| CA2286408A1 (en) | The use of msm | |
| JP2004262775A5 (US20050276830A1-20051215-C00012.png) | ||
| WO2000013649A3 (fr) | Utilisation du gluconate de lithium dans la fabrication d'un medicament pour le traitement de l'herpes et de la dermite seborrheique | |
| SE9700617D0 (sv) | New composition | |
| JP2003502270A5 (US20050276830A1-20051215-C00012.png) | ||
| AU2001235527A1 (en) | Use of orally administered dehydroepiandrosterone, precursors and derivatives thereof in order to improve the papery aspect of the skin |
